Targeting Cancer in the Human Body
The signs and symptoms of cancer can greatly vary within the body, depending on the type of cancer and the stage. But regardless of type and stage, a depletion of the body’s resources results in some common mental and physical stressors. Read More There are also numerous factors that can increase the progression of cancer. It is important to understand all of the secondary effects and effectors within the body to look for potential areas to target for prevention and treatment.
When a person learns they have cancer, often they become stressed, fearful and confused; they just can’t relax. The body’s resulting stress response allows the cancer to take over, even accelerate, the patient’s depreciation. The field of psychoneuroimmunology is now looking at alternative ways to target cancer, in an individualistic and holistic manner, with a bigger focus on mental and emotional factors. NuCalm can help alleviate some of the psychological and physiological effects of cancer and improve quality of life by, predictably and rapidly, putting the brakes on the stress response, giving them peace of mind, clarity, balance and improved sleep quality.
Added Stress is Like a Second Diagnosis
A vicious cycle forms as a cancer diagnosis leads to psychological stress in the patient. Stress can interfere with healing behaviors. Difficulty sleeping and unhealthy coping mechanisms can worsen the condition. This in turn causes more stress. Read More
Chronic stress or toxic stress occurs when the body is in sympathetic nervous system (SNS) dominance for too long with an overactive hypothalamic-pituitary-adrenal (HPA) axis. An overworked SNS and HPA axis cause sustained high levels of epinephrine and cortisol even after an acute stress response ends. These hormones can significantly affect the tumor’s local environment and studies have demonstrated that chronically high levels may lead to cancer growth and spread.
Norepinephrine and epinephrine instigate a cascade of consequences in the development and persistence of cancer such as angiogenesis (blood vessel growth in the tumor) as well as tumor cell migration and proliferation.
Chronic amounts of glucocorticoids in the body, like cortisol, inhibit chemotherapy’s positive tumor-killing effects by “turning on” the tumor cells’ survival genes.
Over the long-term, stress hormones also work to suppress the immune response. Our immune systems should play a vital role in fighting off the disease alongside the prescribed treatments, but when poorly functioning, it is little surprise that cancer progresses or recurs, or other illnesses develop.
Luckily, Stress is Now Easier to Manage
NuCalm is the world’s only patented, clinically proven neuroscience technology to manage stress without drugs or side effects. NuCalm is a reset button that dramatically lowers the stress response and allows the body’s natural healing processes to thrive. Read More
NuCalm is designed to treat stress. It acts directly on the stress-responding systems embedded in the center of the brain including the hypothalamic-pituitary-adrenal (HPA) axis.
The HPA axis is supposed to turn off after a stressful experience, but cannot do so in chronic stress. NuCalm resets this feedback loop by inhibiting the activity in this region with GABA supplementation (the inhibitory neurotransmitter) and cranial electrical stimulation (responsible for facilitating the absorption of GABA). Greater inhibitory activity is linked to less stress and anxiety, as it brings about a state of calm and relaxation.
NuCalm allows not only the patient but also families and friends of the patient to deal with their stress head-on. Alleviating chronic stress is essential for the patient’s immune function and recovery. Alleviating stress in the patient’s support network is equally important because research shows that patients with better social support are less likely to regress in their disease.
NuCalm relieves patients of their stress and gives them the opportunity to focus on their health and recovery.
Autonomic Nervous System (ANS) Dysfunction
There is an unfavorable two-way relationship between cancer and the autonomic nervous system. As cancer grows, the ANS becomes more imbalanced. As the ANS is more imbalanced, it may actually be supporting the tumor’s development. Read More
The Autonomic Nervous System (ANS) is adversely affected by cancer and by cancer treatments. These consequences are often under-evaluated by physicians during checkups and likely worsen a patient’s quality of life.
Primary ANS tumors are located in ANS structures like the adrenal medulla, or the sympathetic or parasympathetic nerves. One clinical symptom of these types of tumors, caused by the oversecretion of norepinephrine and/or epinephrine, may be severe sustained or episodic hypertension.
Non-primary ANS tumors are not located in the ANS structures but still indirectly contribute to autonomic dysfunction. Tumors in the central nervous system (brain and spinal cord) can over-excite the brain causing seizures. Tumors affecting the peripheral nervous system or organs outside of the nervous system entirely may be associated with a variety of autonomic syndromes which affect the autonomic regulation of the cardiorespiratory, digestive and immune systems.
Finally, autonomic nerves can interact with cancerous cells as a malignant tumor grows and develops its own blood vasculature. Studies have shown that increased neurotransmitter and hormone release from ANS cells into cancer cells can actually favor the unhindered growth and development of malignant tumors.
Maintain ANS Balance with NuCalm
The body needs ANS balance to have a good shot at fighting cancer. NuCalm suspends the body into parasympathetic dominance allowing the ANS to shift away from a stressed, overly excited, sympathetic state and giving the body the opportunity for rest and recovery. Read More
NuCalm is a patented neurotechnology that restores autonomic nervous system (ANS) balance. It has the potential to alleviate some of the effects that stress, chronic inflammation and cancer have on the ANS. NuCalm can affect the ANS in two ways: it entrains the brainwaves to frequency ranges associated with catecholamine production and it increases overall brain inhibition allowing the parasympathetic nervous system to prosper.
A low heart rate variability (HRV) (little changes in heartbeat frequencies) can be indicative of an imbalance between the sympathetic and parasympathetic components of the ANS. HRV analysis can show which arm of the ANS is dominant. In Dr. Hranicky’s cancer patients, it was evident that the sympathetic nervous system was in control. However, after only 5 min of NuCalm these patients showed on average a 92% decrease in sympathetic power. The ratio of the sympathetic versus the parasympathetic also decreased, suggesting that the body entered a state of parasympathetic dominance.
When the body is parasympathetically dominant, it has the opportunity to combat some of the ANS dysfunction brought on by cancer. Using NuCalm as a supplemental treatment may be highly beneficial in helping reduce certain ANS symptoms of cancer and benefits cancer patients on multiple fronts.